ArticleJournal for immunotherapy of cancer2023

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.

Brwa Ali Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.